LRMR - Larimar Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

LRMR is currently covered by 3 analysts with an average price target of $-3.6. This is a potential upside of $-10.87 (-149.52%) from yesterday's end of day stock price of $7.27.

Larimar Therapeutics's activity chart (see below) currently has 16 price targets and 27 ratings on display. The stock rating distribution of LRMR is 81.82% BUY and 18.18% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.58% with an average time for these price targets to be met of 408.33 days.

Highest price target for LRMR is $25, Lowest price target is $14, average price target is $-3.6.

Most recent stock forecast was given by JONATHAN WOLLEBEN from JMP on 13-Feb-2024. First documented stock forecast 16-Oct-2015.

Best performing analysts who are covering LRMR - Larimar Therapeutics:

Jason Butler Yatin Suneja Jonathan Wolleben Edward Tenthoff Myles Minter Joseph Schwartz

Currently out of the existing stock ratings of LRMR, 9 are a BUY (81.82%), 2 are a HOLD (18.18%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

25

$17.73 (243.88%)

17

1 months 15 days ago

1/8 (12.5%)

$16.26 (186.04%)

728

Buy

14

$6.73 (92.57%)

12

10 months 11 days ago

2/3 (66.67%)

$10.31 (279.40%)

411

Hold

1 years 6 months 9 days ago

0/1 (0%)

$12 (70.59%)

Hold

5

4 years 6 months 23 days ago

1/4 (25%)

$-17.92 (-78.18%)

992

Hold

8

4 years 6 months 23 days ago

2/2 (100%)

$-26.68 (-76.93%)

318

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LRMR (Larimar Therapeutics) average time for price targets to be met?

On average it took 408.33 days on average for the stock forecasts to be realized with a an average price target met ratio 39.58

Which analyst has the current highest performing score on LRMR (Larimar Therapeutics) with a proven track record?

JASON BUTLER

Which analyst has the current lower performing score on LRMR (Larimar Therapeutics) with a proven track record?

JOSEPH SCHWARTZ

Which analyst has the most public recommendations on LRMR (Larimar Therapeutics)?

Jason Butler works at JMP and has 5 price targets and 3 ratings on LRMR

Which analyst is the currently most bullish on LRMR (Larimar Therapeutics)?

Jonathan Wolleben with highest potential upside - $17.73

Which analyst is the currently most reserved on LRMR (Larimar Therapeutics)?

Edward Tenthoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?